Toxicogenomic Analysis of Mainstream Tobacco Smoke-Exposed Mice Reveals Repression of Plasminogen Activator Inhibitor-1 Gene in Heart

References

• A. Agren, T. Kolmert, B. Wiman, and S. Schulman. 2007. Low PAI-1 activity in relation to the risk for perioperative bleeding complications in transurethral resection of the prostate. Thromb. Res. 119:715–721.
   PubMedGoogle Scholar
• Y. Benjamini, and Y. Hochberg. 1995. Controlling the false discovery rate: A practical and powerful approach to multiple testing. J. R. Stat. Soc. B 57:289–300.
   Google Scholar
• P. Carmeliet, L. Kieckens, L. Schoonjans, B. Ream, A. van Nuffelen, G. Prendergast, M. Cole, R. Bronson, D. Collen, and R. C. Mulligan. 1993a. Plasminogen activator inhibitor-1 gene-deficient mice. I. Generation by homologous recombination and characterization. J Clin. Invest. 92:2746–2755.
   PubMed Web of Science ®Google Scholar
• P. Carmeliet, J. M. Stassen, L. Schoonjans, B. Ream, J. J. van den Oord, M. De Mol, R. C. Mulligan, and D. Collen. 1993b. Plasminogen activator inhibitor-1 gene-deficient mice. II. Effects on hemostasis, thrombosis, and thrombolysis. J. Clin. Invest. 92:2756–2760.
   PubMed Web of Science ®Google Scholar
• L. Chen, M. Chester, and J. C. Kaski. 1995. Clinical factors and angiographic features associated with premature coronary artery disease. Chest 108:364–369.
   PubMed Web of Science ®Google Scholar
• X. Cui, J. T. Hwang, J. Qiu, N. J. Blades, and G. A. Churchill. 2005. Improved statistical tests for differential gene expression by shrinking variance components estimates. Biostatistics 6:59–75.
   PubMed Web of Science ®Google Scholar
• C. Dellas, and D. J. Loskutoff. 2005. Historical analysis of PAI-1 from its discovery to its potential role in cell motility and disease. Thromb. Haemost. 93:631–640.
   PubMed Web of Science ®Google Scholar
• G. Dong, A. H. Schulick, M. B. DeYoung, and D. A. Dichek. 1996. Identification of a cis-acting sequence in the human plasminogen activator inhibitor type-1 gene that mediates transforming growth factor-beta1 responsiveness in endothelium in vivo. J. Biol. Chem. 271:29969–29977.
   PubMed Web of Science ®Google Scholar
• H. Dong, M. Wade, A. Williams, A. Lee, G. R. Douglas, and C. Yauk. 2005. Molecular insight into the effects of hypothyroidism on the developing cerebellum. Biochem. Biophys. Res. Commun. 330:1182–1193.
   PubMedGoogle Scholar
• C. Flotho, A. Paulun, C. Batz, and C. M. Niemeyer. 2007. AKAP12, a gene with tumour suppressor properties, is a target of promoter DNA methylation in childhood myeloid malignancies. Br. J. Haematol. 138:644–650.
   PubMed Web of Science ®Google Scholar
• A. Furuyama, S. Hirano, E. Koike, and T. Kobayashi. 2006. Induction of oxidative stress and inhibition of plasminogen activator inhibitor-1 production in endothelial cells following exposure to organic extracts of diesel exhaust particles and urban fine particles. Arch. Toxicol. 80:154–162.
   PubMed Web of Science ®Google Scholar
• A. Gils, and P. J. Declerck. 2004. The structural basis for the pathophysiological relevance of PAI-I in cardiovascular diseases and the development of potential PAI-I inhibitors. Thromb. Haemost. 91:425–437.
   PubMed Web of Science ®Google Scholar
• A. Hamsten, U. de Faire, G. Walldius, G. Dahlen, A. Szamosi, C. Landou, M. Blomback, and B. Wiman. 1987. Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction. Lancet 2:3–9.
   PubMed Web of Science ®Google Scholar
• R. D. Hautamaki, D. K. Kobayashi, R. M. Senior, and S. D. Shapiro. 1997. Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice. Science 277:2002–2004.
   PubMed Web of Science ®Google Scholar
• I. Juhan-Vague, J. Valadier, M. C. Alessi, M. F. Aillaud, J. Ansaldi, C. Philip-Joet, P. Holvoet, A. Serradimigni, and D. Collen. 1987. Deficient t-PA release and elevated PA inhibitor levels in patients with spontaneous or recurrent deep venous thrombosis. Thromb. Haemost. 57:67–72.
   PubMed Web of Science ®Google Scholar
• M. K. Kerr. 2003. Design considerations for efficient and effective microarray studies. Biometrics 59:822–828.
   PubMed Web of Science ®Google Scholar
• C. Kluft, J. H. Verheijen, A. F. Jie, D. C. Rijken, F. E. Preston, H. M. Sue-Ling, J. Jespersen, and A. O. Aasen. 1985. The postoperative fibrinolytic shutdown: a rapidly reverting acute phase pattern for the fast-acting inhibitor of tissue-type plasminogen activator after trauma. Scand. J. Clin. Lab. Invest. 45:605–610.
   PubMed Web of Science ®Google Scholar
• D. J. Loskutoff, M. Sawdey, and J. Mimuro. 1989. Type 1 plasminogen activator inhibitor. Prog. Hemost. Thromb. 9:87–115.
   PubMedGoogle Scholar
• D. C. Montgomery. 2001. Design and analysis of experiments, 5th ed. New York: John Wiley & Sons.
   Google Scholar
• D. E. Newby, R. A. Wright, C. Labinjoh, C. A. Ludlam, K. A. Fox, N. A. Boon, and D. J. Webb. 1999. Endothelial dysfunction, impaired endogenous fibrinolysis, and cigarette smoking: A mechanism for arterial thrombosis and myocardial infarction. Circulation 99:1411–1415.
   PubMed Web of Science ®Google Scholar
• I. Njolstad, E. Arnesen, and P. G. Lund-Larsen. 1996. Smoking, serum lipids, blood pressure, and sex differences in myocardial infarction. A 12-year follow-up of the Finnmark Study. Circulation 93:450–456.
   PubMed Web of Science ®Google Scholar
• O. Ozdemir, Y. Karaaslan, O. Ozcebe, S. Dundar, and S. Kirazli. 1992. The acute effect of smoking on platelet and endothelial release reaction is suppressed in chronic smokers. Thromb. Res. 65:263–274.
   PubMedGoogle Scholar
• C. Pasten, N. C. Olave, L. Zhou, E. M. Tabengwa, P. E. Wolkowicz, and H. E. Grenett. 2007. Polyphenols downregulate PAI-1 gene expression in cultured human coronary artery endothelial cells: Molecular contributor to cardiovascular protection. Thromb. Res. 121:59–65.
   PubMed Web of Science ®Google Scholar
• M. Peterfy, J. Phan, P. Xu, and K. Reue. 2001. Lipodystrophy in the fld mouse results from mutation of a new gene encoding a nuclear protein, lipin. Nat. Genet. 27:121–124.
   PubMed Web of Science ®Google Scholar
• J. F. Price, P. I. Mowbray, A. J. Lee, A. Rumley, G. D. Lowe, and F. G. Fowkes. 1999. Relationship between smoking and cardiovascular risk factors in the development of peripheral arterial disease and coronary artery disease: Edinburgh Artery Study. Eur. Heart J. 20:344–353.
   PubMed Web of Science ®Google Scholar
• R. N. Proctor. 2004. The global smoking epidemic: a history and status report. Clin. Lung Cancer 5:371–376.
   PubMedGoogle Scholar
• R Development Core Team. 2005R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing.
   Google Scholar
• A. Santamaria, M. Borrell, J. Mateo, C. Vallve, and J. Fontcuberta. 2007. What is the clinical impact of low plasminogen activator inhibitor-1 (PAI-1) activity? A case report and study of the incidence of low PAI-1 antigen in a healthy population. J. Thromb˙. Haemost. 5:1565–1566.
   PubMedGoogle Scholar
• M. S. Sawdey, and D. J. Loskutoff. 1991. Regulation of murine type 1 plasminogen activator inhibitor gene expression in vivo. Tissue specificity and induction by lipopolysaccharide, tumor necrosis factor-alpha, and transforming growth factor-beta. J. Clin. Invest. 88:1346–1353.
   PubMed Web of Science ®Google Scholar
• J. Schneiderman, M. S. Sawdey, M. R. Keeton, G. M. Bordin, E. F. Bernstein, R. B. Dilley, and D. J. Loskutoff. 1992. Increased type 1 plasminogen activator inhibitor gene expression in atherosclerotic human arteries. Proc. Natl. Acad. Sci. USA 89:6998–7002.
   PubMed Web of Science ®Google Scholar
• C. B. Sherman. 1991. Health effects of cigarette smoking. Clin. Chest Med. 12:643–658.
   PubMed Web of Science ®Google Scholar
• A. S. Simani, S. Inoue, and J. C. Hogg. 1974. Penetration of the respiratory epithelium of guinea pigs following exposure to cigarette smoke. Lab. Invest. 31:75–81.
   PubMed Web of Science ®Google Scholar
• M. J. Thirman, J. H. Albrecht, M. A. Krueger, R. R. Erickson, D. L. Cherwitz, S. S. Park, H. V. Gelboin, and J. L. Holtzman. 1994. Induction of cytochrome CYPIA1 and formation of toxic metabolites of benzo[a]pyrene by rat aorta: A possible role in atherogenesis. Proc. Natl. Acad. Sci. USA 91:5397–401.
   PubMed Web of Science ®Google Scholar
• N. Umegaki, K. Tamai, H. Nakano, R. Moritsugu, T. Yamazaki, K. Hanada, I. Katayama, and Y. Kaneda. 2007. Differential regulation of karyopherin alpha 2 expression by TGF-beta1 and IFN-gamma in normal human epidermal keratinocytes: Evident contribution of KPNA2 for nuclear translocation of IRF-1. J. Invest. Dermatol. 127:1456–1464.
   PubMedGoogle Scholar
• D. E. Vaughan. 2005. PAI-1 and atherothrombosis. J. Thromb. Haemost. 3:1879–1883.
   PubMed Web of Science ®Google Scholar
• Y. Wang, C. Barbacioru, F. Hyland, W. Xiao, K. L. Hunkapiller, J. Blake, F. Chan, C. Gonzalez, L. Zhang, and R. R. Samaha. 2006. Large scale real-time PCR validation on gene expression measurements from two commercial long-oligonucleotide microarrays. BMC Genom. 7:59.
   PubMed Web of Science ®Google Scholar
• H. Wu, K. M. Kerr, X. Cui, and G. A. Churchill. 2003. MAANOVA: A software package for the analysis of spotted cDNA microarray experiments.. The analysis of gene expression data: Methods and software, eds. G. E. Parmigiani, E. S. Garrett, R. A. Irizarry, and S. L. Zeger, pp. 313–431. New York: Springer-Verlag..
   Google Scholar
• G. Xiang, M. D. Schuster, T. Seki, P. Witkowski, S. Eshghi, and S. Itescu. 2005. Downregulated expression of plasminogen activator inhibitor-1 augments myocardial neovascularization and reduces cardiomyocyte apoptosis after acute myocardial infarction. J. Am. Coll. Cardiol. 46:536–541.
   PubMed Web of Science ®Google Scholar
• Y. H. Yang, S. Dudoit, P. Luu, D. M. Lin, V. Peng, J. Ngai, and T. P. Speed. 2002. Normalization for cDNA microarray data: A robust composite method addressing single and multiple slide systematic variation. Nucleic Acids Res. 30:e15.
   PubMed Web of Science ®Google Scholar
• C. L. Yauk, M. L. Berndt, A. Williams, A. Rowan-Carroll, G. R. Douglas, and M. R. Stampfli. 2007. Mainstream tobacco smoke causes paternal germ-line DNA mutation. Cancer Res. 67:5103–106.
   PubMed Web of Science ®Google Scholar